Value creation for medical devices: lessons to be learnt from the pharmaceutical sector
This article was originally published in Clinica
Executive Summary
Over the past few years the pharmaceutical industry has discovered a new talisman - the economic evaluation of medicines. Dr Neil Johnson looks at the achievements of the last few years and outlines the pitfalls that medical device and diagnostic companies should avoid as they become more and more involved in the field.